SCHEMBL803191

SCHEMBL803191

COC(=O)c1cc2c(cc1F)[C@H](N(C(=O)c1ccccc1Cl)C(C)C)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 6/20 0.40
HPGD P15428 3/20 0.37
TSHR P16473 2/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 2/20 0.36
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
CYP1A2 P05177 1/20 0.36
PFKFB3 Q16875 1/20 0.36
NR1I2 O75469 1/20 0.36
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 2/20 0.35
SLC6A9 P48067 1/20 0.35
SLC6A5 Q9Y345 1/20 0.35
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785962 0.90 TRPM8 (0.41) TRPM8HPGDTSHRALDH1A1NR1I2
SCHEMBL784631 0.90 TRPM8 (0.41) TRPM8HPGDTSHRALDH1A1NR1I2
SCHEMBL803189 0.87 TRPM8 (0.43) TRPM8HPGDTSHRTAS1R3TAS1R1
SCHEMBL803510 0.86 SLC6A2 (0.41) TRPM8HPGDTSHRALDH1A1HSD17B10
SCHEMBL803210 0.80 SLC6A2 (0.39) TRPM8ALDH1A1NR1I2KMT2AMAPT
SCHEMBL10274922 0.79 NPC1 (0.36) TRPM8HPGDALDH1A1CYP1A2PFKFB3
SCHEMBL785967 0.79 TRPM8 (0.47) TRPM8HPGDTSHRTAS1R3TAS1R1
SCHEMBL785968 0.79 TRPM8 (0.47) TRPM8HPGDTSHRTAS1R3TAS1R1
SCHEMBL803198 0.79 TRPM8 (0.43) TRPM8HPGDALDH1A1KDM4E
SCHEMBL803577 0.79 TRPM8 (0.43) TRPM8HPGDTSHRTAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 TRPM8 180/4885HPGD 1082/4885TSHR 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.